In short. How to judge a biostimulator result objectively, when maintenance is reasonable, and how to recognise the point at which more sessions stop being the answer.
Key points
- There is no dissolving enzyme for a biostimulator, so an over-treated face has to be waited out.
- The discipline of stopping at the right point is not caution for its own sake; it is the only reversible decision available to you once treatment has begun.
Finishing a course raises two questions that the treatment itself does not answer: did it work, and should I keep going? Both are answered with evidence rather than feeling, and the evidence is a pair of photographs rather than an impression. Getting this right is what separates a course that ends well from one that continues because nobody defined the end.
Judge against the baseline, not against memory
You see your face every day, and memory adjusts to a gradual change in either direction. That is why the fair comparison is a standardised photograph — same light, same angle, same distance, same three-month point — set beside the baseline taken before the first session. If the photographs show a difference you can describe, the course has done something. If they show none, that is an answer too, and more useful than mirror-checking.
The stopping rule, applied
A full course at proper intervals that changes nothing visible in photographs means further sessions are unlikely to help. The honest next step is a different plan: a reassessment of whether the concern was volume at all, or really laxity or descent. Continuing to inject because stopping feels like admitting failure is the behaviour the stopping rule exists to prevent.
More is not better, and cannot be taken back
There is no dissolving enzyme for a biostimulator, so an over-treated face has to be waited out. The discipline of stopping at the right point is not caution for its own sake; it is the only reversible decision available to you once treatment has begun.
What maintenance honestly looks like
The effect is at its best somewhere between nine and eighteen months and then declines gradually. The reasonable pattern is a review when you notice the change, with the interval set from your own result rather than from a fixed calendar or a standing appointment. Some patients return once, some more often, and some decide the change is no longer worth the waiting — all three are legitimate, and none means the treatment failed.
Signals to stop rather than continue
- No visible change in standardised photographs after a full course at proper intervals, which is the clearest signal there is.
- A standing appointment or a package that continues without anyone re-examining whether it is still doing anything.
- An area that has become lumpy, uneven or over-full, where adding more would make the problem harder rather than better.
The wider point is that a biostimulator course is a bounded decision rather than an ongoing membership. It has a beginning, a course, a review and an end, and the end is defined in advance by what the photographs show. A patient who leaves with that structure has got what the treatment can give; a patient who leaves with a rolling package has bought the habit instead. When the result fades and you are deciding whether to return, ask whether the same reasoning that made the first course sensible still applies — and if your circumstances or your tolerance for the waiting have changed, it is reasonable to stop there.
Frequently asked questions
How do I judge the result objectively rather than by memory?
Against photographs taken in the same light, at the same angle and at the same distance, not against how you felt before treatment. Memory adjusts to a gradual change in either direction, which is why a baseline photograph and a three-month comparison are the instrument rather than a formality.
When is it right to stop having sessions?
When a full course at proper intervals has produced no change you can see in standardised photographs. At that point further sessions rarely help, and the honest next step is a different plan rather than more of the same. Stopping on that basis is a clinical decision, not a failure of commitment.
What does honest maintenance look like after the first course?
A review when you notice the change rather than a standing appointment, with intervals set from how your own result is fading. The effect declines gradually somewhere after nine to eighteen months, and the right time to return is when the photographs and the mirror agree that it has.
Risks & Limitations
- Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment and may need assessment and treatment rather than simply resolving.
- Irreversibility: a biostimulator cannot be dissolved. An uneven or unwanted result has to be managed over time, not switched off.
- Infection or inflammation at the injection site.
- Asymmetry or over-correction. Over-treatment in an area that cannot be dissolved is harder to correct than under-treatment.
- Lumpiness or irregularity in the first weeks while the material settles, which usually resolves but occasionally does not.
- Bruising, swelling, tenderness and occasional headache after treatment.
- A biostimulator does not lift descended tissue and does not remove fat. The effect is gradual over months, it is not permanent, and maintenance treatment is required.
When to Seek Care
- A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
- Redness, warmth, swelling or pus at an injection site, or fever.
- Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
- Increasing pain, or pain out of proportion to the injection.
- Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable and skin safety information
- American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
- U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.